T2	eligibility 313 333	postmenopausal women
T3	control 608 615	placebo
T4	intervention 586 596	raloxifene
T1	intervention 67 79	bazedoxifene
T5	intervention 80 100	conjugated estrogens
T6	outcome-Measure 927 949	percent breast density
T7	No-of-participants 1026 1029	507
T8	average-age 1070 1081	55.2-56.3 y
T9	outcome 1113 1167	mammographic breast density from baseline to 24 months
